Entrada Therapeutics Inc (TRDA) net margin is 14.4%
Entrada Therapeutics Inc (TRDA) net margin is 14.4% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full TRDA research page for quote, filings, and the rest of the model. This satellite exists so “Entrada Therapeutics Inc net margin” can rank with the actual number, then send you to /stock/trda.